261 studies found for:    cardiac CT OR CAT scan OR coronary artery scan | Open Studies | NIH, U.S. Fed
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer
Conditions: Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer
Interventions: Other: 18F-Fluoromisonidazole;   Drug: Carboplatin;   Procedure: Computed Tomography;   Radiation: External Beam Radiation Therapy;   Radiation: Fludeoxyglucose F-18;   Radiation: Image-Guided Adaptive Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Procedure: Positron Emission Tomography
2 Unknown  The Addition of Cardiac CT to Exercise Treadmill Testing in the Evaluation of Angina
Condition: Angina
Intervention:
3 Recruiting Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease
Conditions: Chronic Kidney Disease;   Pulmonary Embolism;   Renal Artery Stenosis;   Pulmonary Cancer
Interventions: Drug: Low Volume iso-osmolar non-ionic radio contrast medium;   Drug: Acetylcysteine Inhalation;   Drug: Sodium Bicarbonate Solution;   Procedure: 64-MDCT Scanning
4 Recruiting SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy
Conditions: Lung Carcinoma;   Malignant Neoplasm
Interventions: Procedure: Computed Tomography;   Radiation: Fludeoxyglucose F-18;   Procedure: Positron Emission Tomography;   Procedure: Single Photon Emission Computed Tomography;   Radiation: Technetium Tc-99m Albumin Aggregated;   Drug: Technetium Tc-99m DTPA
5 Recruiting Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer
Conditions: Clear Cell Renal Cell Carcinoma;   Metastatic Renal Cell Cancer;   Stage III Renal Cell Cancer;   Stage IV Renal Cell Cancer
Interventions: Biological: Aldesleukin;   Procedure: Computed Tomography;   Drug: Entinostat;   Radiation: Fludeoxyglucose F-18;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Procedure: Positron Emission Tomography
6 Recruiting 18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules
Conditions: Lung Carcinoma;   Solitary Pulmonary Nodule;   Cigarette Smoking Behavior
Interventions: Procedure: Computed Tomography;   Radiation: fluorodeoxyglucose F-18;   Radiation: Fluorine F 18 L-glutamate Derivative BAY94-9392;   Other: Laboratory Biomarker Analysis;   Procedure: Positron Emission Tomography;   Procedure: Positron Emission Tomography (PET)
7 Not yet recruiting 68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment
Conditions: Prostate Adenocarcinoma;   PSA Failure;   Recurrent Prostate Carcinoma
Interventions: Procedure: Computed Tomography;   Radiation: Gallium Ga 68-labeled PSMA Ligand Glu-urea-Lys(Ahx)-HBED-CC;   Other: Laboratory Biomarker Analysis;   Procedure: Positron Emission Tomography
8 Recruiting FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia
Condition: Untreated Adult Acute Myeloid Leukemia
Interventions: Drug: Chemotherapy;   Procedure: Computed Tomography;   Drug: Cytarabine;   Other: Fluorothymidine F-18;   Other: Laboratory Biomarker Analysis;   Procedure: Positron Emission Tomography
9 Not yet recruiting FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy
Conditions: Estrogen Receptor Positive;   HER2/Neu Negative;   Progesterone Receptor Negative;   Progesterone Receptor Positive;   Stage IV Breast Cancer
Interventions: Procedure: Computed Tomography;   Radiation: F-18 16 Alpha-Fluoroestradiol;   Other: Laboratory Biomarker Analysis;   Procedure: Positron Emission Tomography
10 Recruiting Dual Energy Computed Tomography (CT) in Finding Bone Metastases in Patients With Cancer
Conditions: Malignant Neoplasm;   Metastatic Malignant Neoplasm to the Bone
Interventions: Radiation: virtual non-calcium dual-energy computed tomography;   Radiation: computed tomography
11 Recruiting Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery
Condition: Stage IIIA Non-Small Cell Lung Cancer
Interventions: Drug: Cisplatin;   Procedure: Computed Tomography;   Drug: Docetaxel;   Radiation: Fludeoxyglucose F-18;   Drug: Gemcitabine Hydrochloride;   Drug: Pemetrexed Disodium;   Procedure: Positron Emission Tomography
12 Recruiting Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery
Conditions: Multiple Endocrine Neoplasia Type 1;   Pancreatic Neuroendocrine Carcinoma
Interventions: Radiation: Computed Tomography Perfusion Imaging;   Other: Laboratory Biomarker Analysis;   Biological: Ziv-Aflibercept
13 Recruiting Dual Energy CT for Ischemia Determination Compared to "Gold Standard" Non-Invasive and Invasive Techniques
Condition: Ischemia
Intervention: Procedure: CT and stress test
14 Recruiting 18F-DOPA-PET in Planning Surgery in Patients With Gliomas
Conditions: Malignant Glioma;   Recurrent Brain Neoplasm
Interventions: Procedure: Biopsy;   Procedure: Computed Tomography;   Procedure: Diffusion Weighted Imaging;   Drug: Fluorine F 18 Fluorodopa;   Other: Laboratory Biomarker Analysis;   Procedure: Perfusion Magnetic Resonance Imaging;   Procedure: Positron Emission Tomography;   Procedure: Therapeutic Conventional Surgery
15 Recruiting Evaluation of Breast CT
Condition: Breast Cancer
Intervention: Radiation: computed tomography
16 Recruiting 18F-FES PET/CT in Imaging Patients With Desmoid Tumors
Conditions: Deep Fibromatosis/Desmoid Tumor;   Familial Adenomatous Polyposis
Interventions: Radiation: F-18 16 Alpha-Fluoroestradiol;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Other: Laboratory Biomarker Analysis
17 Recruiting 18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors
Conditions: Malignant Primary Brain Neoplasm;   Metastatic Malignant Neoplasm to the Brain;   Recurrent Adult Brain Neoplasm
Interventions: Radiation: Fluorothymidine F-18;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography
18 Recruiting PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer
Conditions: Metastatic Malignant Neoplasm in the Brain;   Recurrent Non-Small Cell Lung Carcinoma;   Stage IIA Non-Small Cell Lung Carcinoma;   Stage IIB Non-Small Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Non-Small Cell Lung Cancer
Interventions: Drug: Carboplatin;   Procedure: Computed Tomography;   Radiation: Intensity-Modulated Radiation Therapy;   Drug: Paclitaxel;   Procedure: Positron Emission Tomography;   Radiation: Proton Beam Radiation Therapy
19 Recruiting Myeloid Derived Suppressor Cells Clinical Assay in Finding and Monitoring Kidney Cancer
Conditions: Healthy Subject;   Metastatic Renal Cell Cancer;   Recurrent Renal Cell Carcinoma;   Stage I Renal Cell Cancer;   Stage II Renal Cell Cancer;   Stage III Renal Cell Cancer
Interventions: Procedure: Computed Tomography;   Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis;   Procedure: Magnetic Resonance Imaging
20 Recruiting 18F-FSPG PET/CT for Cancer Patients on Therapy
Conditions: B-Cell Neoplasm;   Estrogen Receptor Negative;   HER2/Neu Negative;   Metastatic Renal Cell Cancer;   Progesterone Receptor Negative;   Stage III Mesothelioma;   Stage III Renal Cell Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer;   Stage IV Mesothelioma;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Renal Cell Cancer;   Triple-Negative Breast Carcinoma
Interventions: Procedure: Computed Tomography;   Radiation: Fluorine F 18 L-glutamate Derivative BAY94-9392;   Procedure: Positron Emission Tomography;   Procedure: Magnetic Resonance Imaging

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years